CAPRICOR THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Capricor Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Capricor Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.05M, a 19.5% increase year-over-year.
  • Capricor Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $9.33M, a 39.7% increase year-over-year.
  • Capricor Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.39M, a 65.8% increase from 2022.
  • Capricor Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.46M, a 50.3% increase from 2021.
  • Capricor Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.97M, a 51.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.33M $2.05M +$334K +19.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $9M $2.15M +$534K +33% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $8.46M $3.27M +$1.07M +48.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $7.39M $1.86M +$713K +62.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $6.68M $1.72M +$630K +58% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $6.05M $1.62M +$461K +39.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $5.59M $2.19M +$1.13M +106% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $4.46M $1.15M +$368K +47.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $4.09M $1.09M +$367K +50.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $3.72M $1.16M +$446K +62.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.28M $1.07M +$312K +41.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $2.97M $780K +$306K +64.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 $2.66M $720K +$234K +48% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $2.43M $712K +$7.95K +1.13% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $2.42M $753K +$465K +162% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $1.95M $474K +$345K +269% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $1.61M $487K +$262K +116% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.35M $704K +$580K +467% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $766K $288K +$64.6K +29% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $701K $128K -$252K -66.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 $953K $225K -$205K -47.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $1.16M $124K -$299K -70.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.46M $223K -$212K -48.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $1.67M $381K -$32.8K -7.93% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $1.7M $430K +$2.95K +0.69% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $1.7M $423K +$25.1K +6.32% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.67M $435K -$36.9K -7.83% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $1.71M $413K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $427K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $398K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $472K +$181K +62.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q1 2016 $1.28M $291K -$282K -49.2% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-13
Q4 2015 $1.56M $383K +$243K +174% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 $1.32M $267K +$118K +79.8% Jun 30, 2015 Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $1.2M $343K +$235K +219% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-14
Q1 2015 $968K $572K +$488K +577% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $480K $140K +$53.7K +62.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $426K $148K +$76.8K +107% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $350K $108K +$42.9K +66.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $307K $84.5K +$43.2K +104% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $264K $85.8K +$78.4K +1052% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 $185K $71.6K +$20.4K +39.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $165K $64.8K -$17.4K -21.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $182K $41.4K -$130K -75.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $313K $7.45K Oct 1, 2012 Dec 31, 2012 10-K 2013-06-21
Q3 2012 $51.2K -$198K -79.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $82.2K -$88.3K -51.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $172K Jan 1, 2012 Mar 31, 2012 10-Q 2013-06-21
Q3 2011 $249K Jul 1, 2011 Sep 30, 2011 10-Q 2013-06-21
Q2 2011 $171K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.